Physician profile
Amit Lahav
NPI 1518054113
$34,055.31
in general payments reported to CMS, 2019-2025
16 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $8,355 · 2021: $3,060 · 2022: $229 · 2023: $165 · 2024: $1,247 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084 · Travel and Lodging: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.05 |
| Travel and Lodging | $453.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $30,598.30 | 2019-2022 | |
| Medacta USA, INC. | $834.79 | 2022-2024 | Gmk Sphere |
| Pacira Therapeutics, INC. | $535.95 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $356.87 | 2024 | Airsupra, Farxiga, Breztri |
| Depuy Synthes Sales INC. | $326.19 | 2019-2023 | Orthovisc, Peak |
| Vericel Corporation | $249.98 | 2022-2024 | Maci |
| Horizon Therapeutics Plc | $232.84 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $132.82 | 2021 | |
| Novo Nordisk INC | $124.98 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.52 | 2019 | |
| Medtronic Vascular, INC. | $114.29 | 2019 | |
| Stryker Corporation | $109.55 | 2021-2023 | Mako |
| Medtronic USA, INC. | $107.73 | 2019 | |
| Merck Sharp & Dohme LLC | $101.92 | 2019 | |
| Medical Device Business Services, INC. | $91.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $16.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Lahav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.